COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics
- PMID: 37237997
- PMCID: PMC10215473
- DOI: 10.3390/antiox12051133
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics
Abstract
An uncontrolled inflammatory response during SARS-CoV-2 infection has been highlighted in several studies. This seems to be due to pro-inflammatory cytokines whose production could be regulated by vitamin D, ROS production or mitogen-activated protein kinase (MAPK). Several genetic studies are present in the literature concerning genetic influences on COVID-19 characteristics, but there are few data on oxidative stress, vitamin D, MAPK and inflammation-related factors, considering gender and age. Therefore, the aim of this study was to evaluate the role of single nucleotide polymorphisms in these pathways, clarifying their impact in affecting COVID-19-related clinical features. Genetic polymorphisms were evaluated through real-time PCR. We prospectively enrolled 160 individuals: 139 patients were positive for SARS-CoV-2 detection. We detected different genetic variants able to affect the symptoms and oxygenation. Furthermore, two sub-analyses were performed considering gender and age, showing a different impact of polymorphisms according to these characteristics. This is the first study highlighting a possible contribution of genetic variants of these pathways in affecting COVID-19 clinical features. This may be relevant in order to clarify the COVID-19 etiopathogenesis and to understand the possible genetic contribution for further SARS infections.
Keywords: MAPK; SARS-CoV-2; vitamin D.
Conflict of interest statement
A.C. received honoraria from Gilead, Insmed, Janssen-Cilag, M.S.D., Viiv and he is currently receiving research grants from Gilead and Viiv. G.D.P. and S.B. received honoraria from Abbvie, B.M.S., Gilead, Janssen-Cilag, M.S.D, Viiv. A.B. advisory board from ViiV Healthcare, personal fees from Janssen Cilag. The other authors declare no conflict of interest.
References
-
- WHO WHO Director-Generals Opening Remarks at the Media Briefing on COVID-19—March 2020. [(accessed on 30 March 2023)]. Available online: who.int/director-general/speeches/detail/who-director-general-s-opening-....
-
- CDC Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals. [(accessed on 19 May 2023)]; Available online: cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.
-
- Beltran-Garcia J., Osca-Verdegal R., Pallardo F.V., Ferreres J., Rodriguez M., Mulet S., Sanchis-Gomar F., Carbonell N., Garcia-Gimenez J.L. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants. 2020;9:936. doi: 10.3390/antiox9100936. - DOI - PMC - PubMed
-
- WHO Coronavirus Disease (COVID-19): How Is It Transmitted? [(accessed on 17 April 2023)]. Available online: https://www.who.int/news-room/questions-and-answers/item/coronavirus-dis....
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
